Cargando…
Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways
Erythropoietin (EPO) is recognized for its function in erythropoiesis; however, its potential antifibrotic effect against liver fibrosis remains unknown. This study examined whether EPO affects thioacetamide (TAA)-induced liver fibrosis by concentrating on the Toll-like receptor 4 (TLR4) cascade and...
Autores principales: | Elbaset, Marawan A., Mohamed, Bassim M. S. A., Moustafa, Passant E., Mansour, Dina F., Afifi, Sherif M., Esatbeyoglu, Tuba, Abdelrahman, Sahar S. M., Fayed, Hany M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465256/ https://www.ncbi.nlm.nih.gov/pubmed/37649466 http://dx.doi.org/10.1155/2023/5514248 |
Ejemplares similares
-
Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
por: Elbaset, Marawan A., et al.
Publicado: (2023) -
Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
por: ElBaset, Marwan A., et al.
Publicado: (2022) -
Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
por: Mohammed, Omima S., et al.
Publicado: (2023) -
The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats
por: Abdel-Rahman, Rehab F., et al.
Publicado: (2021) -
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
por: Abdelkader, Noha F., et al.
Publicado: (2022)